Retail & Wholesale » Retail | Charmacy Pharmaceutical Co. Ltd.

Charmacy Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
36,986.00
57,810.60
51,282.00
93,340.30
51,075.80
53,018.50
Depreciation, Depletion & Amortization
12,575.50
12,239.20
11,079.10
11,015.90
16,314.20
22,576.80
Other Funds
630.90
629.30
-
3,147.70
107,167.30
44,163.20
Funds from Operations
43,221.40
66,191.10
42,457.60
82,202.90
99,940.00
118,915.90
Changes in Working Capital
7,209.50
107,628.20
172,440.60
215,576.70
136,373.00
58,357.70
Net Operating Cash Flow
36,012.00
41,437.10
214,898.20
133,373.80
36,433.00
60,558.20
Capital Expenditures
6,439.80
5,596.70
2,655.70
25,656.10
144,857.10
Sale of Fixed Assets & Businesses
277.60
857.10
37.00
184.60
2,609.50
Purchase/Sale of Investments
-
-
175,449.10
-
-
Net Investing Cash Flow
82,886.10
45,521.00
212,800.10
39,933.00
142,247.50
Cash Dividends Paid - Total
-
-
56,740.10
24,699.20
37,360.00
Issuance/Reduction of Debt, Net
51,813.70
2,252.80
13,198.20
152,726.30
273,966.00
Net Financing Cash Flow
52,444.60
2,882.00
162,365.50
131,174.80
129,438.70
Net Change in Cash
5,570.50
6,966.00
164,463.70
42,132.00
51,280.50
Free Cash Flow
29,572.20
47,033.80
212,242.60
159,029.90
181,290.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
2,030.00
842.70
Other Sources
1,204,240.60
1,529,531.20
-
2,355,455.80
-
Change in Capital Stock
-
-
232,303.90
-
-
Exchange Rate Effect
-
-
-
-
2,038.70
Other Uses
1,280,964.40
1,479,270.50
34,732.30
2,369,917.30
-

About Charmacy Pharmaceutical Co.

View Profile
Address
No. 235 Song Shan North Road
Shantou Guangdong 515041
China
Employees -
Website http://www.chmyy.com
Updated 07/08/2019
Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business. It also provides consultation services on pharmaceutical products. It mainly distributes western medicine, Chinese patent medicine and healthcare products to downstream distributors and retail terminals.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.